MR 409 [CAS 1445155-39-4]
Partner: MedChemexpress LLC
| CAS No: | 1445155-39-4 |
| Applications: | Cancer-programmed cell death |
| MW: | 3395.91 |
| Formula: | C153H252N44O43 |
| SMILES: | [{N-Me}-Y-{D-Ala}-DAIFTNSYR-{Orn}-VL-{Abu}-QLSAR-{Orn}-LLQDI-{Nle}-DR-NHMe] |
| Purity: | 99.90 |
| Description: | MR 409 is a selected growth hormone-releasing hormone (GHRH) agonist. MR 409 has remarkable neuroprotective effects through enhancing endogenous neurogenesis in cerebral ischemic mice. MR 409 also inhibits the in vivo growth of lung cancer[1][2][3][4]. |
| Shipping Conditions: | Ship on cold packs |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
